Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative

Carregando...
Imagem de Miniatura
Citações na Scopus
1852
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER MEDICAL ASSOC
Autores
MERIKANGAS, Kathleen R.
JIN, Robert
HE, Jian-Ping
KESSLER, Ronald C.
LEE, Sing
SAMPSON, Nancy A.
HU, Chiyi
KARAM, Elie G.
Citação
ARCHIVES OF GENERAL PSYCHIATRY, v.68, n.3, p.241-251, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Context: There is limited information on the prevalence and correlates of bipolar spectrum disorder in international population-based studies using common methods. Objectives: To describe the prevalence, impact, patterns of comorbidity, and patterns of service utilization for bipolar spectrum disorder (BPS) in the World Health Organization World Mental Health Survey Initiative. Design, Setting, and Participants: Crosssectional, face-to-face, household surveys of 61 392 community adults in 11 countries in the Americas, Europe, and Asia assessed with the World Mental Health version of the World Health Organization Composite International Diagnostic Interview, version 3.0, a fully structured, lay-administered psychiatric diagnostic interview. Main Outcome Measures: Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) disorders, severity, and treatment. Results: The aggregate lifetime prevalences were 0.6% for bipolar type I disorder (BP-I), 0.4% for BP-II, 1.4% for subthreshold BP, and 2.4% for BPS. Twelve-month prevalences were 0.4% for BP-I, 0.3% for BP-II, 0.8% for subthreshold BP, and 1.5% for BPS. Severity of both manic and depressive symptoms as well as suicidal behavior increased monotonically from subthreshold BP to BP-I. By contrast, role impairment was similar across BP subtypes. Symptom severity was greater for depressive episodes than manic episodes, with approximately 74.0% of respondents with depression and 50.9% of respondents with mania reporting severe role impairment. Three-quarters of those with BPS met criteria for at least 1 other disorder, with anxiety disorders (particularly panic attacks) being the most common comorbid condition. Less than half of those with lifetime BPS received mental health treatment, particularly in low-income countries, where only 25.2% reported contact with the mental health system. Conclusions: Despite cross-site variation in the prevalence rates of BPS, the severity, impact, and patterns of comorbidity were remarkably similar internationally. The uniform increases in clinical correlates, suicidal behavior, and comorbidity across each diagnostic category provide evidence for the validity of the concept of BPS. Treatment needs for BPS are often unmet, particularly in low-income countries.
Palavras-chave
Referências
  1. Angst Jules, 2002, World Psychiatry, V1, P146
  2. Morgan VA, 2005, BIPOLAR DISORD, V7, P326, DOI 10.1111/j.1399-5618.2005.00229.x
  3. Leon AC, 1997, INT J PSYCHIAT MED, V27, P93
  4. Grant BF, 2005, J CLIN PSYCHIAT, V66, P1205
  5. Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293
  6. Gureje O, 2006, BRIT J PSYCHIAT, V188, P465, DOI 10.1192/bjp.188.5.465
  7. Angst J, 2003, J AFFECT DISORDERS, V73, P133, DOI 10.1016/S0165-0327(02)00322-1
  8. Angst J, 1998, J AFFECT DISORDERS, V50, P143, DOI 10.1016/S0165-0327(98)00142-6
  9. Pini S, 2005, EUR NEUROPSYCHOPHARM, V15, P425, DOI 10.1016/j.euroneuro.2005.04.011
  10. Duffy A, 2007, BIPOLAR DISORD, V9, P828
  11. Merikangas KR, 2008, ARCH GEN PSYCHIAT, V65, P47, DOI 10.1001/archgenpsychiatry.2007.18
  12. Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8
  13. Zimmermann P, 2009, ARCH GEN PSYCHIAT, V66, P1341, DOI 10.1001/archgenpsychiatry.2009.158
  14. Keller MB, 2006, J CLIN PSYCHIAT, V67, P5
  15. Kessler RC, 2006, J AFFECT DISORDERS, V96, P259, DOI 10.1016/j.jad.2006.08.018
  16. Henin A, 2005, BIOL PSYCHIAT, V58, P554, DOI 10.1016/j.biopsych.2005.06.010
  17. Angst J, 2010, AM J PSYCHIAT, V167, P1194, DOI 10.1176/appi.ajp.2010.09071011
  18. Tohen M, 2009, BIPOLAR DISORD, V11, P453, DOI 10.1111/j.1399-5618.2009.00726.x
  19. Wittchen HU, 2003, INT J NEUROPSYCHOPH, V6, P145, DOI 10.1017/S146114570300333X
  20. Lewinsohn PM, 2002, CHILD ADOL PSYCH CL, V11, P461, DOI 10.1016/S1056-4993(02)00005-6
  21. Kessler RC, 2004, INT J METH PSYCH RES, V13, P122, DOI 10.1002/mpr.169
  22. Strakowski SM, 2000, CLIN PSYCHOL REV, V20, P191, DOI 10.1016/S0272-7358(99)00025-2
  23. YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429
  24. Waraich P, 2004, CAN J PSYCHIAT, V49, P124
  25. Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543
  26. Judd LL, 2003, J AFFECT DISORDERS, V73, P123, DOI 10.1016/S0165-0327(02)00332-4
  27. Merikangas KR, 2009, CLIN PSYCHOL-SCI PR, V16, P121
  28. Bauer M, 2005, EPILEPSIA, V46, P8
  29. Cooper J., 1972, PSYCHIAT DIAGNOSIS N
  30. First M. B., 2002, STRUCTURED CLIN INTE
  31. Goodwin FK, 2007, MANIC DEPRESSIVE ILL
  32. Gracious BL, 2002, J AM ACAD CHILD PSY, V41, P1350, DOI 10.1097/01.CHI.0000024841.60748.9A
  33. Halli S. S., 1992, ADV TECHNIQUES POPUL
  34. Heeringa S. G., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P14
  35. Kramer M, 1969, Am J Psychiatry, V10 Suppl, P1
  36. Pennell B. E., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P33
  37. SAS Institute Inc, 2001, SAS STAT SOFTW CHANG
  38. Sherazi R, 2006, HARVARD REV PSYCHIAT, V14, P273, DOI 10.1080/10673220601070047
  39. Wang PS, 2007, WORLD PSYCHIATRY, V6, P177
  40. Wolter K, 1985, INTRO VARIANCE ESTIM
  41. World Bank, 2008, DAT STAT
  42. World Health Organization, 2002, WORLD HLTH REP 2002
  43. Zubin J, 1969, Am J Psychiatry, V10 Suppl, P12